Watch out for an immediate break out in this stock.
This is a fundamentally strong specialty chemical stock with an operating margin >30%. 75% percent of their business is in Pharma chemicals, which is a high margin business. As per earning calls, management seems to be confident of maintaining the margin and expect the business to grow multifold in coming years. Its trading at a low P/E of 17.5 while other pharma chemical companies trade at a P/E of about 50.
This is a fundamentally strong specialty chemical stock with an operating margin >30%. 75% percent of their business is in Pharma chemicals, which is a high margin business. As per earning calls, management seems to be confident of maintaining the margin and expect the business to grow multifold in coming years. Its trading at a low P/E of 17.5 while other pharma chemical companies trade at a P/E of about 50.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.